NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

血糖監測系統的全球市場

Blood Glucose Monitoring Systems

出版商 Global Industry Analysts, Inc. 商品編碼 992589
出版日期 內容資訊 英文 456 Pages
商品交期: 最快1-2個工作天內
價格
血糖監測系統的全球市場 Blood Glucose Monitoring Systems
出版日期: 2021年04月01日內容資訊: 英文 456 Pages
簡介

全球血糖監測系統的市場規模,預計在分析期間(2020年∼2027年)將以4.6%的年複合成長率增長,從2020年的94億美元,到2027年達到129億美元。

本報告所分析的市場區隔之一的自我監測部門,在分析期間中預計將以4.6%的年複合成長率增長,達到88億美元。

本報告提供全球血糖監測系統市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • 競爭的市場佔有率:各市場區隔
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

IV. 競爭

  • 企業簡介:36公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP21367

Abstract:

Global Blood Glucose Monitoring Systems Market to Reach $12.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Blood Glucose Monitoring Systems estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at aCAGR of 4.6% over the period 2020-2027. Self-Monitoring, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$8.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Continuous segment is readjusted to a revised 4.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 7.5% CAGR

The Blood Glucose Monitoring Systems market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Self-Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Continuous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Fingertip Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Alternate Site Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Self / Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Type 1 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Type 2 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Gestational Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 43: Canada Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Canada 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 52: Canada Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Canada Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Canada 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 55: Japan Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 58: Japan Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Japan Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Japan 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 61: Japan Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Japan Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Japan 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 64: Japan Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Japan Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Japan 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 67: China Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: China Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: China 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 70: China Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: China Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: China 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 73: China Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: China Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: China 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 76: China Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: China Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: China 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 79: Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 82: Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 85: Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 88: Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 91: Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 94: France Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: France Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: France 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 97: France Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: France Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: France 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 100: France Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: France Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: France 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 103: France Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: France Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: France 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 106: Germany Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Germany Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Germany 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 109: Germany Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Germany Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Germany 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 112: Germany Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Germany Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Germany 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 115: Germany Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Germany Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: Germany 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 118: Italy Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Italy Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: Italy 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 121: Italy Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Italy Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: Italy 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 124: Italy Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Italy Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: Italy 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 127: Italy Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Italy Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: Italy 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 130: UK Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 131: UK Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: UK 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 133: UK Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 134: UK Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: UK 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 136: UK Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 137: UK Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 138: UK 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 139: UK Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 140: UK Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 141: UK 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 142: Spain Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Spain Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 144: Spain 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 145: Spain Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Spain Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 147: Spain 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 148: Spain Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Spain Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 150: Spain 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 151: Spain Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Spain Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 153: Spain 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 154: Russia Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Russia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 156: Russia 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 157: Russia Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Russia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 159: Russia 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 160: Russia Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Russia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 162: Russia 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 163: Russia Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Russia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 165: Russia 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 166: Rest of Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 168: Rest of Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 169: Rest of Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 171: Rest of Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 172: Rest of Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 174: Rest of Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 175: Rest of Europe Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 177: Rest of Europe 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 178: Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 179: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 180: Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 181: Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 183: Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 184: Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 186: Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 187: Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 189: Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 190: Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 192: Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 193: Australia Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Australia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 195: Australia 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 196: Australia Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Australia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 198: Australia 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 199: Australia Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Australia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 201: Australia 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 202: Australia Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Australia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 204: Australia 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 205: India Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 206: India Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 207: India 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 208: India Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 209: India Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 210: India 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 211: India Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 212: India Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 213: India 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 214: India Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 215: India Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 216: India 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 217: South Korea Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 218: South Korea Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 219: South Korea 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 220: South Korea Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 221: South Korea Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 222: South Korea 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 223: South Korea Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 224: South Korea Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 225: South Korea 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 226: South Korea Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 227: South Korea Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 228: South Korea 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 229: Rest of Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 232: Rest of Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 235: Rest of Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 237: Rest of Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 238: Rest of Asia-Pacific Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 240: Rest of Asia-Pacific 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 241: Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 242: Latin America Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 243: Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 244: Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 246: Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 247: Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 249: Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 250: Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 252: Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 253: Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 255: Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 256: Argentina Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Argentina Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 258: Argentina 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 259: Argentina Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Argentina Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 261: Argentina 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 262: Argentina Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Argentina Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 264: Argentina 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 265: Argentina Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Argentina Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 267: Argentina 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 268: Brazil Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Brazil Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 270: Brazil 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 271: Brazil Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Brazil Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 273: Brazil 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 274: Brazil Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 275: Brazil Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 276: Brazil 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 277: Brazil Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 278: Brazil Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 279: Brazil 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 280: Mexico Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 281: Mexico Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 282: Mexico 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 283: Mexico Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 284: Mexico Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 285: Mexico 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 286: Mexico Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 287: Mexico Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 288: Mexico 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 289: Mexico Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Mexico Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 291: Mexico 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 292: Rest of Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 294: Rest of Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 295: Rest of Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 297: Rest of Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 298: Rest of Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 300: Rest of Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 301: Rest of Latin America Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 302: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 303: Rest of Latin America 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 304: Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 305: Middle East Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 306: Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 307: Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 308: Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 309: Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 310: Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 311: Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 312: Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 313: Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 314: Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 315: Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 316: Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 317: Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 318: Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 319: Iran Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 320: Iran Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 321: Iran 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 322: Iran Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 323: Iran Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 324: Iran 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 325: Iran Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 326: Iran Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 327: Iran 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 328: Iran Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 329: Iran Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 330: Iran 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 331: Israel Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 332: Israel Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 333: Israel 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 334: Israel Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 335: Israel Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 336: Israel 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 337: Israel Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 338: Israel Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 339: Israel 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 340: Israel Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 341: Israel Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 342: Israel 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 343: Saudi Arabia Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 344: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 345: Saudi Arabia 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 346: Saudi Arabia Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 347: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 348: Saudi Arabia 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 349: Saudi Arabia Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 350: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 351: Saudi Arabia 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 352: Saudi Arabia Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 353: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 354: Saudi Arabia 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 355: UAE Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 356: UAE Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 357: UAE 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 358: UAE Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 359: UAE Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 360: UAE 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 361: UAE Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 362: UAE Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 363: UAE 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 364: UAE Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 365: UAE Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 366: UAE 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 367: Rest of Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 368: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 369: Rest of Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 370: Rest of Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 371: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 372: Rest of Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 373: Rest of Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 374: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 375: Rest of Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 376: Rest of Middle East Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 377: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 378: Rest of Middle East 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 379: Africa Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 380: Africa Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 381: Africa 15-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2012, 2020 & 2027
    • TABLE 382: Africa Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 383: Africa Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 384: Africa 15-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2012, 2020 & 2027
    • TABLE 385: Africa Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 386: Africa Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 387: Africa 15-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2012, 2020 & 2027
    • TABLE 388: Africa Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 389: Africa Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 390: Africa 15-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 36